1. Probiodrug Ag (51 from 71 patents)

2. Prosidion Limited (4 from 16 patents)

3. Other (2 from 832,680 patents)

4. Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. (2 from 4,804 patents)

5. Osi Pharmaceuticals, Inc. (2 from 118 patents)

6. Probiodrug (2 from 2 patents)

7. Forschungszentrum Juelich Gmbh (1 from 204 patents)

8. Vivoryon Therapeutics N.v. (1 from 5 patents)

9. Vivoryon Therapeutics Ag (1 from 1 patent)

10. Forschungszentrum Julich Gmbh (302 patents)

11. Royalty Pharma Collection Trust (0 patent)

1. 12378186 - Inhibitors of meprin α and β

2. 11703511 - Anti-isoAsp7 amyloid β (Aβ) antibodies and uses thereof

3. 11186572 - Bacterial glutaminyl cyclases and inhibitors thereof for use in the treatment of periodontitis

4. 10975019 - Inhibitors of meprin α and β

5. 9676843 - Uses of antibodies directed against amyloid-β

6. 9657089 - Diagnostic antibody assay

7. 9650362 - Inhibitors

8. 9611296 - Peptides that bind to amino-truncated amyloid-beta-peptide and use of said peptides

9. 9610368 - Radiolabelled glutaminyl cyclase (QC) inhibitors and uses of same

10. 9512115 - Inhibitors

11. 9462793 - Mouse carrying a knock-out mutation of the Qpct-gene

12. 9277737 - Mouse models carrying a knock-out mutation of the QPCTL-gene

13. 9181233 - Inhibitors of glutaminyl cyclase

14. 9173885 - Inhibitors

15. 9157918 - Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)